Acadia Pharmaceuticals buy UBS Group AG
Start price
06.01.26
/
50%
€23.07
Target price
06.01.27
€34.12
Performance (%)
7.80%
Price
20.08.26
€24.87
Summary
This prediction is currently active. With a performance of 7.80%, the BUY prediction by UBS_Group_AG for Acadia Pharmaceuticals is trending in the right direction. This prediction currently runs until 06.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 1.015% | 1.015% |
| iShares Core DAX® | -1,28 % | 4,21 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % |
| iShares S&P 500 | -2,31 % | -0,10 % |
Comments by UBS_Group_AG for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (NASDAQ:ACAD) was given a new $40.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by UBS_Group_AG for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€24.89
17.08.26
17.08.26
-
17.08.27
17.08.27
-0.08%
20.08.26
20.08.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.96
09.09.25
09.09.25
€33.13
09.09.26
09.09.26
18.65%
20.08.26
20.08.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.15
08.08.25
08.08.25
€30.87
08.08.26
08.08.26
18.82%
09.08.26
09.08.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.56
08.08.24
08.08.24
€21.10
08.08.25
08.08.25
43.94%
09.08.25
09.08.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.80
17.10.23
17.10.23
€31.28
17.10.24
17.10.24
-36.33%
18.10.24
18.10.24